Differentiation of Human Pluripotent Cell-derived Neural Rosettes to Dopaminergic Neurons by Small Molecules

26 September 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A major challenge for regenerative medicine is differentiation of pluripotent cells to one of the hundreds of specialized cell types in the human body, without the introduction of animal traits or pathogens that would make them useless for transplantation. One approach to this problem is differentiation promoted by small molecules. In this work, a chemical library was prepared based on compounds that are neurotrophic for rat dopaminergic neurons and mimic some effects of glial-cell derived neurotrophic factor (GDNF). Members of a library of a N-(heteroarylsulfamoyl)-phenyl cinnamides were studied in a low-throughput phenotypic screen for their ability to promote differentiation of human pluripotent stem cell-derived neural rosettes to dopaminergic neurons, with morphological scoring. A hit series was identified and the cells resulting from compound treatments were shown by phenotypic assays to exhibit traits of the A9 dopaminergic neuron subtype. The method is effective with both hES cell- and hiPS cell-derived rosettes.

Keywords

Combinatorial library
phenotypic screening
neural differentiation

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.